Effect of Concomitant Medications on Treatment Response and Survival in De Novo Metastatic Prostate Cancer: Secondary Analysis of the LATITUDE Study

It is unclear whether exposure to commonly prescribed medications influences survival and treatment response in patients with de novo high risk metastatic prostate cancer (mPCa) treated with androgen receptor pathway inhibitors (ARPIs).

Source: European Journal of Cancer - September 20, 2023 Category: Cancer & Oncology Authors: Soumyajit Roy, Fred Saad, Christopher J.D. Wallis, Yilun Sun, Daniel E. Spratt, Rishav Akilla, Amar U. Kishan, Shawn Malone, Scott C. Morgan Tags: Original Research Source Type: research